HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus.

Abstract
Through December 1994, 41 healthcare workers with a documented seroconversion to human immunodeficiency virus (HIV) in temporal association to an occupational exposure were reported to the Centers for Disease Control and Prevention (CDC). Each tested positive for HIV antibodies within 12 months of the occupational exposure. Two (5%) of the 41 tested negative for HIV antibodies >6 months following the occupational exposure but were seropositive within 12 months of the injury. Both denied any subsequent exposures to HIV after the initial exposure, and in one case genetic sequencing confirmed the source of the infection. Four of the healthcare workers took postexposure zidovudine prophylaxis; each reported an acute retroviral syndrome within 6 weeks of their exposure, and each of the four seroconverted to HIV within 6 months of the exposure. Our data suggest that zidovudine prophylaxis does not delay the development of HIV antibodies beyond 6 months. Because many of the healthcare workers had follow-up testing at irregular intervals, with long periods between tests, it was not possible to define precisely when seroconversion occurred. However, our findings are compatible with previously published estimates that 95% of infected persons will develop HIV antibodies within 6 months of infection.
AuthorsC A Ciesielski, R P Metler
JournalThe American journal of medicine (Am J Med) Vol. 102 Issue 5B Pg. 115-6 (May 19 1997) ISSN: 0002-9343 [Print] United States
PMID9845512 (Publication Type: Journal Article, Review)
Chemical References
  • HIV Antibodies
Topics
  • HIV Antibodies (blood)
  • HIV Infections (etiology, immunology)
  • HIV Seropositivity (immunology)
  • Health Personnel
  • Humans
  • Occupational Exposure (adverse effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: